844ODocetaxel for hormone-naïve prostate cancer: Results from long-term follow-up of metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476) and sub-group analysis by metastatic burden
Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Calvert, J, Attard, G, Chowdhury, S, Dearnaley, D, Douis, H, Gillessen, S, Jones, R, Malik, Z, Mason, M D, Millman, R, Parker, C, Rush, H L, Omlin, A G, SyVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz248.001
Date:
October, 2019
File:
PDF, 106 KB
english, 2019